Skip to main content
SpringerLink
Log in

Current therapies for treatment of cutaneous leishmaniasis in India

  • Review
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Marsden, P. D. Current concepts in parasitology. Leishmaniasis. N. Engl. J. Med. 300 (1979) 350–352.

    Google Scholar 

  2. Turk, J. L., Bryceson, A. D. M. Immunological phenomena in leprosy and related disease. Adv. Immunol. 13 (1971) 209–266.

    PubMed  Google Scholar 

  3. Ridley, D. S. The pathogenesis of cutaneous leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 73 (1979) 150–160.

    Article  PubMed  Google Scholar 

  4. Bryceson, A. D. M.: Essays on tropical dermatology. In:Marshall, J. (ed.): Excerpta Media Monograph, Amsterdam 1972, pp. 231–241.

  5. Griffiths, W. A. D., Dutz, W. Repeated tissue sampling with a dental broach. A trial in cutaneous leishmaniasis. Br. J. Dermatol. 93 (1973) 43–45.

    Google Scholar 

  6. Manson-Bahr, P. E. C. Diagnosis. In:Peters, W., Killick-Kendrick, R. (eds.): The leishmaniasis in biology and medicine. Academic Press, London 1987, pp. 703–729.

    Google Scholar 

  7. Kubba, R., Al-Gindan, Y. Some recent observations in cutaneous leishmaniasis. Indian J. Dermatol. Venerol. Leprol. 55 (1989) 7–17.

    Google Scholar 

  8. Berman, J. D., Waddell, D., Hanson, B. D. Biochemical mechanism of the anti-leishmaniasis effect of sodium stibogluconate. Antimicrob. Agents Chemother. 27 (1985) 916–920.

    PubMed  Google Scholar 

  9. Dogra, J. A double blind study on the efficacy of oral dapsone in cutaneous leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 85 (1991) 212–213.

    Article  PubMed  Google Scholar 

  10. Dogra, J., Lal, B. B., Mishra, S. N. Dapsone in the treatment of cutaneous leishmaniasis. Int. J. Dermatol. 25 (1986) 398–400.

    PubMed  Google Scholar 

  11. Dogra, J., Lal, B. B., Misra, S. N. Cutaneous leishmaniasis: therapeutic efficacy of dapsone in the commonly existing subtypes. Indian J. Dermatol. Venerol. Leprol. 55 (1989) 375–377.

    Google Scholar 

  12. Shigeura, H. T., Hen, A. C., Burg, R. W., Skelly, B. J., Hoogsteen, K. Metabolic studies on diphenyl sulfone derivatives in chick macrophages. Biochem. Pharmacol. 24 (1975) 687–691.

    Article  PubMed  Google Scholar 

  13. Berman, J. D., Lee, J. S. Activity of oral drugs againstLeishmania tropica in human macrophagesin vitro. Am. J. Trop. Med. Hyg. 32 (1983) 947–951.

    PubMed  Google Scholar 

  14. Dogra, J., Aneja, N., Lal, B. B., Misra, S. N. Cutaneous leishmaniasis in India. Clinical experience with itraconazole (R 51 211 Janssen). Int. J. Dermatol. 29 (1990) 661–662.

    PubMed  Google Scholar 

  15. Borelli, D. A clinical trial of itraconazole in the treatment of deep mycosis and leishmaniasis. Rev. Infect. Dis. 9 (1987) 557–563.

    Google Scholar 

  16. Gomez, U. F. G., Urcuyo, F., Zaias, N. J. Oral ketoconazole in the treatment of leishmaniasis. Int. J. Dermatol. 21 (1982) 414–416.

    PubMed  Google Scholar 

  17. Jouiffee, D. S. Cutaneous leishmaniasis from Belize-treatment with ketoconazole. Clin. Exp. Dermatol. 11 (1986) 62–68.

    PubMed  Google Scholar 

  18. Berman, J. D., Holz, G. G., Beach, D. H. Effects of ketoconazole on growth and sterol biosynthesis ofLeishmania mexicana promastigotes in culture. Mol. Biochem. Parasitol. 12 (1984) 1–13.

    Article  PubMed  Google Scholar 

  19. Bryceson, A. Therapy in man. In:Peters, W., Killick-Kendrick, R. (eds.): The leishmaniasis in biology and medicine. Academic Press, London 1987, pp. 847–909.

    Google Scholar 

  20. Mutinga, M. J., Mingola, E. N. Alternative treatment of cutaneous leishmaniasis. Afr. J. Med. Sci. 51 (1974) 68–78.

    Google Scholar 

  21. El-On, J., Weinrauch, L., Livshin, R. L. Tropical treatment of recurrent cutaneous leishmaniasis with ointment containing paramomycin and methylbenzathonium chloride. B. M. J. 291 (1985) 704–705.

    Google Scholar 

  22. Zilberstein, D., Dwyer, D. M. Antidepressants cause lethal disruption of membrane function in the human protozoan parasiteLeishmania. Science 226 (1984) 977–979.

    PubMed  Google Scholar 

  23. Hemtzer, B., Kobayashi, T. The ultra structural changes ofLeishmania tropica after treatment with pentamidine. Ann. Trop. Med. Parasitol. 71 (1977) 155–166.

    Google Scholar 

  24. Gunders, A. E. Vaccination: past and future role in control. In:Peters, W., Killick-Kendrick, R. (eds.): The leishmaniasis in biology and medicine. Academic Press, London 1987, pp. 929–941.

    Google Scholar 

  25. Convit, J., Rondon, A., Ulrich, M., Bloom, B., Castellanos, P. L., Pinardi, M. E., Castes, M., Garcia, L. Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis. Lancet i (1987) 401–404.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Shanti Kutir 1, Medical College Road, 334 001, Bikaner, India

    J. Dogra M. D.

Authors
  1. J. Dogra M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dogra, J. Current therapies for treatment of cutaneous leishmaniasis in India. Infection 20, 189–191 (1992). https://doi.org/10.1007/BF02033055

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02033055

Keywords

Search

Navigation